Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy.
暂无分享,去创建一个
[1] A. Davis,et al. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. , 2002, The Journal of clinical investigation.
[2] M. Silverberg,et al. Pathways for bradykinin formation and inflammatory disease. , 2002, The Journal of allergy and clinical immunology.
[3] W. Tremaine,et al. Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.
[4] M. Kurabayashi,et al. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women , 2001, Menopause.
[5] A. Toutain,et al. Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission. , 2001, The Journal of allergy and clinical immunology.
[6] J. Weiler,et al. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. , 2001, Clinical immunology.
[7] K. Binkley,et al. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.
[8] D. Mccluskey,et al. Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman. , 2000, The American journal of the medical sciences.
[9] K. Bork,et al. Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.
[10] B. Zuraw,et al. Detection of C1 inhibitor mutations in patients with hereditary angioedema. , 2000, The Journal of allergy and clinical immunology.
[11] M. Cicardi,et al. Plasma bradykinin in angio-oedema , 1998, The Lancet.
[12] A. Fletcher,et al. Coexistence of hereditary angioedema and Turner's syndrome. , 1998, Postgraduate medical journal.
[13] H. Schunkert,et al. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. , 1997, Circulation.
[14] H. Bürgi,et al. Type I hereditary angio‐oedema. Variability of clinical presentation and course within two large kindreds , 1997, Journal of internal medicine.
[15] S. Misiti,et al. Estrogen induction and contact phase activation of human factor XII , 1996, Steroids.
[16] J. Gran,et al. Hereditary angio‐oedema: new clinical observations and autoimmune screening, complement and kallikrein‐kinin analyses , 1996, Journal of internal medicine.
[17] I. Fogelman,et al. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women , 1995, The Lancet.
[18] T. Mollnes,et al. Effect of time, temperature and additives on a functional assay of C1 inhibitor. , 1994, Journal of immunological methods.
[19] N. Hoem,et al. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII. , 1994, Thrombosis research.
[20] W. Cunliffe,et al. HORMONALLY EXACERBATED HEREDITARY ANGIOEDEMA , 1992, The Australasian journal of dermatology.
[21] M. Greaves,et al. Angioedema: manifestations and management. , 1991, Journal of the American Academy of Dermatology.
[22] J. Jespersen,et al. Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma. , 1990, Clinical chemistry.
[23] M. Rybojad,et al. Hereditary angioedema and oral contraception. , 1990, Dermatologica.
[24] K. Bork,et al. [Contraception and pregnancy in hereditary angioedema]. , 2008, Deutsche medizinische Wochenschrift.
[25] G. Lagrue,et al. [Hereditary angioneurotic edema: norgestrienone is not effective in every case]. , 1987, Presse medicale.
[26] C. Jamin,et al. Oedéme angioneurotique héréditaire: la norgestriénone n'est pas active dans tous les cas. , 1987 .
[27] W. Cunliffe,et al. Recurrent angioedema: familial and oestrogen‐induced , 1986, The British journal of dermatology.
[28] Wautier Jl,et al. [Norgestrienone, a possible therapeutic agent in hereditary angioneurotic edema]. , 1986 .
[29] O. Ratnoff,et al. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. , 1980, The Journal of laboratory and clinical medicine.
[30] M. Frank. Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema. , 1979, Arthritis and rheumatism.
[31] J. Atkinson,et al. Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.
[32] J. S. O'Toole. Hereditary angio-edema. , 1970, Northwest medicine.
[33] R. L. Wolf. Angioneurotic edema from an oral contraceptive. , 1967, JAMA.
[34] F. Rosen,et al. Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.
[35] R. R. Evans,et al. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.
[36] R. G. Fraser,et al. Hereditary cardiovascular dysplasia. A form of familial cardiomyopathy. , 1961, The American journal of medicine.
[37] W. Osler. HEREDITARY ANGIO‐NEUROTIC ŒDEMA , 1888 .